V. happy to share our paper describing a novel #PROM to assess the impact of #hypoglycaemia on people's #HRQoL. 3 years of rigorous development. Ready for use! Version for use in cost-effectiveness analysis coming soon! @HypoResolve @DiabetologiaJnl

I decided to join @LinkedIn last week. Extremely disappointed. They restricted my account after about a day, with no explanation and the support has been non-existent @LinkedInHelp. Never experienced anything like it… Guess I’ll stick to @ResearchGate

Interested in health economics, social preferences, and health technology assessment? Come do a PhD with global leaders in the field 👑 @donna_rowen Aki Tsuchiya @SCHARRSheffield https://t.co/K0hg6Q4TB8

Happy New Year! 🥳🎆 We’ve got lots of exciting things planned for 2025, including new webinars taking place soon, the 9th Academy Meeting and 5th ECR Meeting in Q1. Here’s our Comms Team giving a sneak peek of the location for the Academy and ECR Meetings - Barcelona! 🇪🇸👇

The Hypo-RESOLVE QoL can be used to generate utilities directly for cost-effectiveness analyses of interventions for #hypoglycaemia - find out more: https://t.co/wPfi2reXJT @HypoResolve w/ @donna_rowen

This festive season, here’s a gift you need 🎁… Current guidelines for assessing understanding in #PROMs are insufficient. @vikki_gale presents a new, robust, evidence-based method: the comprehensibility continuum 💥 https://t.co/w8RtIiYssa w/ @JillCarlton1. #QoL @SCHARRHEDS

A Systematic Review and Quality Assessment of Cardiovascular Disease–Specific Health-Related Quality of Life Instruments: Part II Psychometric Properties @chepa @HEI_mcmaster @hvanspall

Please consider submitting abstracts for our forthcoming UK & Ire EuroQol meeting. And pls pass on the message to colleagues who may be interested. Thanks

Qualitative methods in response-shift research can provide an understanding of what it “looks like” in different patient populations and translate results to clinical experience. Excited to be a part of this team! @ISOQOL @HopkinsOrtho https://t.co/gqa09XkUXf

Health & Social Care Economics Group had a huge presence @ISOQOL in Germany, presented a range of impactful work on quality of life outcomes throughout the life course, from children to older people @FlindersCFI @JulieRatcliff19 @JiaSONG59877915 @rachel_milte @diana_khanna

@vikki_gale gave a phenomenal presentation today about her PhD research. Take home messages: 1) young children CAN provide evidence on item comprehensibility; 2) the Comprehensibility Continuum can be used to quantify and evidence understanding. @SCHARRSheffield @ISOQOL

Vikki (@vikki_gale) knockin’ it out the park with her presentation at #ISOQOL on methods to involve younger children in cognitive debriefing. Fantastic job! @SCHARRSheffield @JillCarlton1

@philapowell presenting @ISOQOL summarized findings of a @EuroQol funded research exploring who should value health-related quality of life in children? Lots of interesting audience questions and more methods research needed! @SCHARRSheffield @SCHARRHEDS @SCHARR_KE

The outstanding @donna_rowen presenting comparative preferences from members of the public and people living with diabetes @ #ISOQOL. Funding from the international @HypoResolve project @SCHARRSheffield @JillCarlton1

Flying ✈️ to the EuroQol Plenary 2024. Looking forward to an engaging couple of days with colleagues

At the 41st EuroQol Plenary 2024, research presented in the scientific sessions will discuss a wide range of topics. Get an early look at what they’ll discuss 👀 ⤵️ #EuroQolPlenary2024 #EQ5D #HealthEconomics

Is #ElonMusk's X a sinking ship? 🛳 As academic & civil society organisations question their presence on the platform, @Andy_Tattersall asks why research organisations might stay (or not) & what alternative #socialmedia they're exploring @LSEImpactBlog. https://t.co/QHbnhRDQXl

With 11K+ accesses over the last three months, it would appear people are interested in our review and results! In collaboration with @AstraZeneca and other colleagues at @SCHARRSheffield including @DanielPollard2

PROQuALS is an exciting new outcome measure that assesses subjectively the HRQoL of people living with #MND, based on how much of a problem different aspects of life are / are not for that individual at that time. Expect updates soon📣

10 new publications on EuroQol instruments, from July 2024, that you NEED to read 📚 ⤵️ 1/

Great to see this paper out online showing the impact of symptomatic and asymptomatic sensor hypoglycaemia from @uffehs @HypoResolve @EASDnews @DTN_UK @LDC_tweets @MadderJules @janespeight